Since the start of her career, Christine has worked at the forefront of healthcare innovation. She has a proven track record of investing in healthcare winners, deep domain expertise, and industry experience commercializing global franchises and building companies. Her meaningful relationships and expertise span pharmaceuticals, diagnostics, genomics, technology, media and finance. At Roche, Christine launched the revolutionary technology polymerase chain reaction (PCR), formed the first cross collaboration between the pharma and diagnostic divisions, was a key member of several marketing teams, and was placed on the Executive Development Track. Christine has helped launch more than 20 products in the pharmaceutical, genomics, technology and diagnostic sectors. She was early in healthcare technology with iScribe and Healtheon/WebMd, and early with genomic diagnostics with Genomic Health.

Most recently, Christine was a key member of the investment team and head of business development at Foresite Capital. While there, Christine was instrumental in building the firm to $1.2B in assets under management over five years, and helped identify and grow some of the most valuable companies within the portfolio, working closely with CEOs and leadership teams. Christine has also been an entrepreneur in the media sector, and was a partner at a technology-focused investment bank acquired by Goldman Sachs.